RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)

Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)

13th Nov 2006, 19:52 GMT

Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis, as indicated by carotid intima-media thickness (CIMT), in patients with type...

View full story at rss.arrivenet.com

Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT) related news:

Latest news from ArriveNet : Health: